R. Aller - Concepedia

Author

R. Aller

Also Known As

Alemayehu Wondu, Aller R, Brian Nolan, Daniel de Luis Román, R ALLER, R Aller, R. ALLER, R. Aller, Rocio Aller, Rocío Aller

520

Publications

7.6K

Citations

H-Index

151

Concepts

All Affiliations

Universidad de Valladolid Hospital Universitario Río Hortega Hospital Clínico Universitario de Valladolid Hospital Universitario Virgen del Rocío Instituto de Biomedicina de Sevilla

About

R. Aller is an author at Universidad de Valladolid specializing in medicine, health sciences, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	87	3.1K
2	Health Sciences	24	66	2.3K
3	Public Health	10	10	291
4	Natural Sciences	1	1	76
5	Social Sciences	1	1	11

R. Aller

190

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. R. Aller, Daniel Antonio de Luis, Olatz Izaola, PubMed	2011	373
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Ramy Younes, Olivier Govaere, Salvatore Petta, Gut	2021	191
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease Ramy Younes, Gian Paolo Caviglia, Olivier Govaere, Journal of Hepatology ObesityMetabolic SyndromeHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver Disease	2021	178
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis Javier Ampuero, Raluca Pais, R. Aller, Clinical Gastroenterology and Hepatology Metabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseLiver Physiology	2019	174
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease Timothy Hardy, Kristy Wonders, Ramy Younes, Contemporary Clinical Trials	2020	128
The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats David Pacheco, Daniel Antonio de Luis, Alejandro Romero, The American Journal of Surgery Metabolic SyndromeGoto-kakizaki RatsEnergy HomeostasisGastrointestinal Peptide HormoneMedicine	2007	117
Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. R. Aller, Olatz Izaola, Susana Gómez, PubMed NutritionPathologyFatty Liver DiseaseObesityMetabolic Syndrome	2015	112
Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 Daniel Antonio de Luis, Nuria Fernández, María Arranz, Journal of Diabetes and its Complications ObesityMetabolic SyndromeBody CompositionDiabetes EpidemiologyCardiovascular Disease	2005	107
Effect of soluble fiber intake in lipid and glucose leves in healthy subjects: a randomized clinical trial R. Aller, Daniel Antonio de Luis, Olatz Izaola, Diabetes Research and Clinical Practice ObesityMetabolic SyndromeNutritionHealthy SubjectsHealth Sciences	2004	104
The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity Javier Ampuero, R. Aller, Rocío Gallego‐Durán, Alimentary Pharmacology & Therapeutics	2018	102

Page 1